N/A
N=85
The Impact of Vocational Rehabilitation on Mentally III Veterans
Posttraumatic Stress Disorder (PTSD)
Bottom Line
View on ClinicalTrials.gov: NCT00333801 ↗Enrolled (actual)
85
Serious AEs
18.8%
Results posted
Mar 2015
Primary outcome: Primary: Obtain Competitive Employment — 12; 32 participants — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Vocational Rehabilitation Program (VRP) (Behavioral); Individual Placement and Support (IPS) (Behavioral)
- Age
- Adult · 19+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Apr 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Obtain Competitive Employment |
12; 32 | <0.001 sig |
| SECONDARY PTSD, Depression, Disability Outcomes |
78.4; 77.3; 12.2; 12.3; 5.0; 4.8 | >0.05 |
| SECONDARY Employment Outcomes (Weeks Competitively Employed) |
6.8; 21.6 | <0.001 sig |
| SECONDARY Employment Outcomes (Days Competitively Employed |
29.3; 83.8 | — |
| SECONDARY Employment Outcomes (Hours Competitively Employed) |
236; 656 | — |
| SECONDARY Employment Outcomes (Gross Income Competitive) |
2,601; 9,264 | — |
| SECONDARY Employment Outcomes (Total Gross Income From All Sources |
3,909; 13,449 | — |
Summary
To study the impact of Individual Placement and Support (IPS) supported employment (SE) compared to treatment-as-usual vocational rehabilitation program (VRP) for veterans with posttraumatic stress disorder (PTSD).
Eligibility Criteria
Inclusion Criteria
- Male or Female
- Age, greater than or equal to 19 and less than 61.
- Enrollment in the TVAMC VRP
- Signed informed consent
- Chronic post-traumatic stress disorder
- Any race or ethnic origin
- Anticipation of remaining in the catchment area for the 12-month study duration
Exclusion Criteria
- Lifetime history of severe traumatic brain injury that has resulted in severe cognitive impairment
- History of schizophrenia, schizoaffective, disorder, or bipolar I disorder
- Pending litigation
- In need of immediate detoxification.
Data sourced from ClinicalTrials.gov (NCT00333801). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.